Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

IL-23R Polymorphisms in Patients with Ankylosing Spondylitis in Korea

IL-HOON SUNG, TAE-HWAN KIM, SO-YOUNG BANG, TAE-JONG KIM, BITNARA LEE, LYNETTE PEDDLE, PROTON RAHMAN, CELIA M.T. GREENWOOD, PINGZHAO HU and ROBERT D. INMAN
The Journal of Rheumatology May 2009, 36 (5) 1003-1005; DOI: https://doi.org/10.3899/jrheum.081121
IL-HOON SUNG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAE-HWAN KIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: thkim@hanyang.ac.kr
SO-YOUNG BANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAE-JONG KIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BITNARA LEE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LYNETTE PEDDLE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PROTON RAHMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CELIA M.T. GREENWOOD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PINGZHAO HU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT D. INMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective. IL23R polymorphisms have been shown to have a significant association with ankylosing spondylitis (AS). To date, these studies have been restricted to Caucasian patients with AS. Our study addresses this relationship in Korean patients with AS.

Methods. A total of 451 patients with AS and 392 ethnically matched healthy controls were enrolled. All patients were native Koreans with AS satisfying the modified New York criteria. In total, 10 single nucleotide polymorphisms (SNP) within the IL-23R gene cluster were genotyped.

Results. No IL-23R SNP were found to be associated with AS in Koreans.

Conclusion. The association of IL23R and AS that is seen in Caucasian patients with AS is not present in Korean patients with AS.

  • IL23R
  • ANKYLOSING SPONDYLITIS

The hallmark of ankylosing spondylitis (AS) is acute and chronic inflammation in the sacroiliac joints, as well as sites of ligamentous and tendinous insertions into bone. Over time, chronic spinal inflammation can lead to complete spinal fusion, a process referred to as ankylosis, and often associated with progressive loss of spinal mobility. The pathogenesis of AS is unknown, but it is well established that genetic factors play a major role in susceptibility to AS. Although HLA-B27 is recognized to be the major gene associated with AS, a role for genes outside the HLA region is increasingly being recognized1,2.

Interleukin 23 (IL-23), a key cytokine in innate and adaptive immune systems, stimulates a CD4+ helper T cell population producing IL-17. IL-23 is very important in animal models of autoimmune arthritis and inflammatory bowel disease (IBD)3,4. Synovial p40 IL12/23 levels are higher in patients with spondyloarthropathy (SpA) compared to osteoarthritis5. IL-23 receptor (IL-23R) is a potent proinflammatory cytokine, which is a key factor in the regulation of Th17 cells. IL-23R polymorphisms have recently been associated with SpA including IBD, psoriasis, and AS in Caucasian populations6–11. IL-23R may be of potential relevance in AS, as there is clinical, immunological, and genetic evidence suggesting an overlap between AS, psoriasis, and IBD. Recently, investigators have reported that the Arg381Gln single-nucleotide polymorphism (SNP) of the IL-23R gene, located on chromosome 1p31, confers a strong protective effect against AS in Caucasians11. However, there have been few studies on these SNP in Asian patients with AS12, particularly Koreans. As previous studies have focused primarily on Caucasian populations of North European ancestry, we set out to study IL-23R variants in a relatively homogenous Korean population with AS.

MATERIALS AND METHODS

Patients and controls

A total of 451 patients with AS and 392 ethnically matched, healthy controls were enrolled for our study. The AS population included 419 men and 32 women, age 35.8 ± 8.79 years [mean ± standard deviation (SD)]. All patients were native Koreans with AS satisfying the modified New York criteria13. Informed consent was obtained from all patients. Clinical information was collected systematically. Of these patients with AS, 3 (0.007%) had IBD and 4 (0.009%) had psoriasis. The control population included 325 men and 67 women, with age of 30.2 ± 6.72 years (mean ± SD). Healthy controls were screened by questionnaire to exclude those with a personal or familial history of arthritis. The study was approved by the ethics committee of Hanyang University in Korea.

Genotyping of IL-23R SNP

DNA was extracted using the Wizard Genomic DNA Purification kit (Promega, Madison, WI, USA). In total, 10 SNP within the IL-23R gene cluster were genotyped in cases and controls. These SNP were selected on the basis of the findings of the recent IBD genome-wide scan and study of Caucasians with AS6,11. The 10 SNP were rs1004819, rs7517847, rs10489629, rs2201841, rs11465804, rs11209026, rs1343151, rs10889677, rs11209032, and rs1495965. Reactions were multiplexed where possible. The detection of SNP was performed using the chip-based matrix-assisted laser desorption ionization time-of-flight mass spectrometry platform (Sequenom, San Diego, CA, USA). Briefly, polymerase chain reaction (PCR) and extension reactions were designed using MassArray Design software (Sequenom). Primers were obtained from Integrated DNA Technologies (Coralville, IA, USA). The PCR primers were used to amplify 5 ng of genomic DNA using standard conditions for MassArray genotyping.

Statistical analysis

Tests of Hardy-Weinberg equilibrium (HWE) were performed for all polymorphic IL-23R SNP, which have HWE p values between 0.15 and 0.79 in control group and 0.07–1 in case group. Single-marker case-control differences were evaluated for all polymorphic IL-23R SNP, using chi-squared tests with 2 degrees of freedom (df), comparing the 3 genotypes in cases versus controls. Further, the Cochrane-Armitage test for trend14 across the 3 genotypes (1 df), and genotypic chi-squared tests were performed for association between each marker and trait using the qtscore function in the GenABEL R package15. All SNP as shown in Table 1 met the quality control (QC) requirement (minor allele frequence > 0.01). Therefore, all 8 SNP met the QC requirements (made in genome-wide association analysis), such as SNP call rate > 95%, HWE p value > 1 ×10–6 (0.000001) and minor allele frequence > 0.01. More than 99% of samples also met the QC requirements, such as sample call rate > 95%. In haplotype-based association analysis, the algorithm proposed by Schaid, et al16 was used to test the association between haplotypes and the trait. The algorithm was implemented in the GenABEL R package (scan.haplo and scan.haplo. 2D functions). We also tested the association between haplotypes constructed based on 3 consecutive loci with the trait.

View this table:
  • View inline
  • View popup
Table 1.

Allele frequency and odds ratios of IL23R variants in a Korean cohort* with ankylosing spondylitis.

RESULTS

In total, 843 subjects were genotyped (451 patients with AS, 392 controls) for IL-23R polymorphisms. Of patients with AS, 98.2% were HLA-B27-positive. In total, 10 SNP within the IL-23R were genotyped, but 2 (rs11456804, rs11209026) were not polymorphic in this population and were removed from analysis. No SNP was found to be associated with AS (Table 1). Of the patients with AS, 153 (34%) had uveitis and 227 (50.3%) had peripheral arthritis. No SNP was found to be associated with AS patients with uveitis or peripheral arthritis. Further, haplotype analyses including either 2 or 3 adjacent markers did not reveal any significant associations.

DISCUSSION

Spondyloarthropathy (SpA) refers to a family of arthritides of unknown etiology with both peripheral and axial manifestations sharing clinical and radiological features as well as genetic predisposing factors. SpA includes AS, reactive arthritis, psoriatic arthritis (PsA), and arthritis related to IBD, as well as undifferentiated SpA. It is evident that IL-23R polymorphisms are associated with multiple disease states among SpA. In AS, there was an association with the Caucasian British, Spanish, Canadian, and American cohorts9–11,17. Further, association has been noted in Crohn’s disease6,7,18, psoriasis, and PsA9. An association with a coding SNP rs11209026 and an intergenic SNP 11465804 appears to be prominent in all these studies. However, these 2 SNP are not polymorphic in the Korean population. When the analysis was repeated excluding AS patients with psoriasis and IBD, no SNP was found to be associated with AS. It is possible that an association might be observed with larger numbers of subjects. Some genes over and above HLA-B27, besides IL-23R, have been recognized as genetic markers in SpA. CARD15 is known to be associated with IBD. The IL-1 gene cluster has been implicated in Caucasian patients with PsA and AS19. However, these genes are not associated in Koreans with AS20–22. These findings suggest that population stratification should really be taken into account in genetic studies, and highlight the importance of investigating additional racial backgrounds other than Caucasians.

Ours is the first study of this candidate gene in non-Caucasians with AS, and the findings differ significantly from recent studies in Caucasian populations, despite the common clinical features between Korean and Caucasian patients with AS and their shared association with HLA-B27. In addition to raising hypotheses about differing genetic pathways to common clinical outcomes, our study is a reminder of the critical issue of appropriate matching of cases and controls in genetic association studies in AS, which are actively being pursued in large population cohorts.

Footnotes

  • Supported by the research fund of Hanyang University (HY-2005-I).

    • Accepted for publication December 10, 2008.

REFERENCES

  1. 1.↵
    1. Brown MA,
    2. Kennedy LG,
    3. MacGregor AJ,
    4. et al
    . Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823–8.
    OpenUrlPubMed
  2. 2.↵
    1. Laval SH,
    2. Timms A,
    3. Edwards S,
    4. et al
    . Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918–26.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Murphy CA,
    2. Langrish CL,
    3. Chen Y,
    4. et al
    . Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003;198:1951–7.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Hue S,
    2. Ahern P,
    3. Buonocore S,
    4. et al
    . Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006;203:2473–83.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Wendling D,
    2. Cedoz JP,
    3. Racadot E
    . Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients. Clin Rheumatol 2009;28:187–90. Epub 2008 Sep 27.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Duerr RH,
    2. Taylor KD,
    3. Brant SR,
    4. et al
    . A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461–3.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Tremelling M,
    2. Cummings F,
    3. Fisher SA,
    4. et al
    . IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 2007;132:1657–64.
    OpenUrlCrossRefPubMed
  8. 8.
    1. Cargill M,
    2. Schrodi SJ,
    3. Chang M,
    4. et al
    . A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80:273–90.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Wellcome Trust Case Control Consortium
    . Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329–37.
    OpenUrlCrossRefPubMed
  10. 10.
    1. Rueda B,
    2. Orozco G,
    3. Raya E,
    4. et al
    . The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008;67:1451–4.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Rahman P,
    2. Inman RD,
    3. Gladman DD,
    4. Reeve JP,
    5. Peddle L,
    6. Maksymowych WP
    . Association of interleukin-23R variants with ankylosing spondylitis. Arthritis Rheum 2008;58:1020–5.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Wang XW,
    2. Huang JX,
    3. Gu JR,
    4. et al
    . Association of the IL23R with AS genetic susceptibility and inflammation related with elevated expression of IL-23 and IL-17 in Chinese population. Clin Exp Rheumatol 2008;26:722.
    OpenUrl
  13. 13.↵
    1. van der Linden S,
    2. Valkenburg HA,
    3. Cats A
    . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.
    OpenUrlPubMed
  14. 14.↵
    1. Sasieni PD
    . From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253–61.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Aulchenko YS,
    2. Ripke S,
    3. Isaacs A,
    4. van Duijn CM
    . GenABEL: an R library for genome-wide association analysis. Bioinformatics 2007;23:1294–6.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Schaid DJ,
    2. Rowland CM,
    3. Tines DE,
    4. Jacobson RM,
    5. Poland GA
    . Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425–34.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Reveille JD,
    2. Zhou X,
    3. Ward MM,
    4. et al
    . The IL23R gene is a major determinant of susceptibility to but not severity of ankylosing spondylitis [abstract]. Arthritis Rheum 2007;Suppl 56:S529.
  18. 18.↵
    1. Hugot JP,
    2. Chamaillard M,
    3. Zouali H,
    4. et al
    . Association of NOD2 leucine rich repeat variants with susceptibility to CD. Nature 2001;411:599–603.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Rahman P,
    2. Sun S,
    3. Peddle L,
    4. et al
    . Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006;54:2321–5.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Kim TH,
    2. Rahman P,
    3. Jun JB,
    4. et al
    . Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populations. J Rheumatol 2004;31:1959–61.
    OpenUrlAbstract/FREE Full Text
  21. 21.
    1. Kim TJ,
    2. Kim TH,
    3. Lee HJ,
    4. et al
    . Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 2008;35:1603–8.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Kim TH,
    2. Stone MA,
    3. Rahman P,
    4. et al
    . Interleukin 1 and nuclear factor-kappa B polymorphisms in ankylosing spondylitis in Canada and Korea. J Rheumatol 2005;32:1907–10.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 5
1 May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
IL-23R Polymorphisms in Patients with Ankylosing Spondylitis in Korea
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
IL-23R Polymorphisms in Patients with Ankylosing Spondylitis in Korea
IL-HOON SUNG, TAE-HWAN KIM, SO-YOUNG BANG, TAE-JONG KIM, BITNARA LEE, LYNETTE PEDDLE, PROTON RAHMAN, CELIA M.T. GREENWOOD, PINGZHAO HU, ROBERT D. INMAN
The Journal of Rheumatology May 2009, 36 (5) 1003-1005; DOI: 10.3899/jrheum.081121

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
IL-23R Polymorphisms in Patients with Ankylosing Spondylitis in Korea
IL-HOON SUNG, TAE-HWAN KIM, SO-YOUNG BANG, TAE-JONG KIM, BITNARA LEE, LYNETTE PEDDLE, PROTON RAHMAN, CELIA M.T. GREENWOOD, PINGZHAO HU, ROBERT D. INMAN
The Journal of Rheumatology May 2009, 36 (5) 1003-1005; DOI: 10.3899/jrheum.081121
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and Metaanalysis
  • The Prognostic Potential of End-Stage Knee Osteoarthritis and Its Components to Predict Knee Replacement: Data From the Osteoarthritis Initiative
  • Efforts to Better Characterize "Antiphospholipid Antibody Nephropathy" for the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria: Renal Pathology Subcommittee Report
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire